Cargando…
ESCAPE: An Open-Label Trial of Personalized Immunotherapy in Critically lll COVID-19 Patients
BACKGROUND: Macrophage activation-like syndrome (MALS) and complex immune dysregulation (CID) often underlie acute respiratory distress (ARDS) in COVID-19. We aimed to investigate the effect of personalized immunotherapy on clinical improvement of critical COVID-19. METHODS: In this open-label prosp...
Autores principales: | Karakike, Eleni, Dalekos, George N., Koutsodimitropoulos, Ioannis, Saridaki, Maria, Pourzitaki, Chryssa, Papathanakos, Georgios, Kotsaki, Antigone, Chalvatzis, Stamatios, Dimakopoulou, Vasiliki, Vechlidis, Nikolaos, Paramythiotou, Elisabeth, Avgoustou, Christina, Ioakeimidou, Aikaterini, Kouriannidi, Elli, Komnos, Apostolos, Neou, Evangelia, Rovina, Nikoletta, Stefanatou, Eleni, Milionis, Haralampos, Nikolaidis, George, Koutsoukou, Antonia, Damoraki, Georgia, Dimopoulos, George, Zoumpos, Vassileios, Eugen-Olsen, Jesper, Akinosoglou, Karolina, Gatselis, Nikolaos K., Koulouras, Vasilios, Gkeka, Eleni, Markou, Nikolaos, Netea, Mihai G., Giamarellos-Bourboulis, Evangelos J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805059/ https://www.ncbi.nlm.nih.gov/pubmed/34852352 http://dx.doi.org/10.1159/000519090 |
Ejemplares similares
-
521. Similarities and Differences in Transcriptomic Host Response between SARS-CoV-2 and Other Viral Infections
por: Thair, Simone A, et al.
Publicado: (2020) -
Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections
por: Thair, Simone A., et al.
Publicado: (2020) -
An open label trial of anakinra to prevent respiratory failure in COVID-19
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2021) -
Acinetobacter baumannii Bloodstream Infections in the COVID-19 Era: A Comparative Analysis between COVID-19 and Non-COVID-19 Critically Ill Patients
por: Andrianopoulos, Ioannis, et al.
Publicado: (2023) -
Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial
por: Leventogiannis, Konstantinos, et al.
Publicado: (2022)